Marko Potman

SOX Antibodies in Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: Frequency and Relation With Survival

Maarten J. Titulaer, Rinse Klooster, Marko Potman et al. · Journal of Clinical Oncology · 2009 · 202 citations · Full text

Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS

Maarten J. Titulaer, Paul Maddison, Jacob K. Sont et al. · Journal of Clinical Oncology · 2011 · 186 citations · Full text

A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation

Bart A. Westerman, A. Koen Braat, Nicole Taub et al. · The Journal of Experimental Medicine · 2011 · 25 citations · Full text

Genetics, Key Mediator, Cell Specialization +16

Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis

Wouter Beumer, Jim Swildens, Teresinha Leal et al. · PLoS ONE · 2019 · 24 citations · Full text

Inflammatory Lung Disease, Molecular Biology, Cellular Physiology +17

Antibodies to active zone protein ERC1 in Lambert–Eaton myasthenic syndrome

Maartje G. Huijbers, Alexander F. Lipka, Marko Potman et al. · Human Immunology · 2013 · 10 citations

Autoimmune Disease, Medicine, Immunology +7